Prevalence of Iron Deficiency Anemia in Gynecological Cancer Patients Undergoing Treatment: A Two-Institution Retrospective Study.
Аннотация
BACKGROUND
Anemia in patients with cancer negatively affects their quality of life and cancer outcomes. However, most patients with chemotherapy-induced anemia (CIA) are not appropriately evaluated or treated, and the prevalence of iron deficiency anemia (IDA) in CIA remains unclear.
METHODS
We retrospectively reviewed the electronic records of patients with gynecological cancer in two tertiary hospitals, between March 2023 and July 2023, and evaluated their anemia status.
RESULTS
We identified 54 patients with CIA, and IDA was found in 74% (40/54) of patients with CIA, including 4% (2/54) with absolute iron deficiency (transferrin saturation (TSAT) < 20% and ferritin < 30 ng/mL), 63% (34/54) with functional iron deficiency (TSAT < 50% and 30 ng/mL < ferritin < 500 ng/mL), and 7% (4/54) with possible functional iron deficiency (TSAT < 50% and 500 ng/mL < ferritin < 800 ng/mL).
CONCLUSIONS
We found that 74% of patients with CIA under gynecologic cancer treatments were IDA in this study.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.